-
S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management
- 2021/02/27
- 再生時間: 25 分
- ポッドキャスト
-
サマリー
あらすじ・解説
Visit http://morningcommutepodcast.com/SGLT2inhibitors3 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will focus on chronic kidney disease (CKD) in patients with or without diabetes and treatment with sodium-glucose cotransporter 2 (SGLT-2) inhibitors. The bottom line is, how should these treatments be incorporated into clinical practice?